The Breakthrough Therapy Designation (BTD) is perhaps one of the most impactful incentives from the FDA as it helps get the product to market much faster than any other expedited approval pathway. Once a drug is successful in getting the BTD, the non-clinical and clinical requirements for market approval are significantly reduced.
All good, but still at .61 and no real volume. Ronin knows and its the only reason I have some faith for the first time in a long time with this company. Happy 4th of July long weekend, so hopefully some PPHM Fireworks next week.